Literature DB >> 21729495

New York Heart Association class assessment by cardiologists and outpatients with congenital cardiac disease: a head-to-head comparison of three patient-based versions.

Dounya Schoormans1, Yuma L Mager, Frans J Oort, Mirjam A G Sprangers, Barbara J M Mulder.   

Abstract

BACKGROUND: The objective of this study was to compare three patient-based New York Heart Association assessments with cardiologist assessments in outpatients with congenital cardiac disease.
METHODS: Consecutive adult outpatients completed three questionnaires in a random order: a patient-based translation of the New York Heart Association classes, a self-constructed questionnaire based on the New York Heart Association classes, and the Specific Activity Scale. The treating cardiologist assessed the New York Heart Association class on the same day. Patient-cardiologist agreement was assessed by calculating percent agreement and weighted kappa. We also explored the level of agreement for patients without co-morbidity.
RESULTS: In all, 86 adults--with a median age of 35.8 years--including 46 women participated. An agreement of 75.6% (weighted kappa is 0.43; probability is smaller than 0.01), 70.6% (weighted kappa is 0.44; probability is smaller than 0.01), and 74.4% (weighted kappa is 0.28; probability is smaller than 0.01) was found between the cardiologist assessment and the patient-based translation, self-constructed questionnaire, and the Specific Activity Scale, respectively. The patient-based translation equally over- and underestimated the New York Heart Association class, whereas the self-constructed questionnaire overestimated and the Specific Activity Scale underestimated the New York Heart Association class. Agreement levels for patients without co-morbidity were higher than agreement levels for the total group.
CONCLUSION: The patient-based translation yielded adequate agreement with cardiologist-assessed New York Heart Association class, showed equal over- and underestimation, and was easy to complete. The patient-based translation with the instruction to only consider functional impairments caused by the congenital cardiac defect is recommended in future studies of outpatients with congenital cardiac disease.

Entities:  

Mesh:

Year:  2011        PMID: 21729495     DOI: 10.1017/S1047951111000825

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  6 in total

1.  Perceived health is partially associated with the symptomatological profile in patients with benign and severe conditions: the case of congenital heart disease.

Authors:  D Schoormans; M A G Sprangers; W Budts; B J M Mulder; S Apers; P Moons
Journal:  Qual Life Res       Date:  2012-07-31       Impact factor: 4.147

2.  Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic Profile.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  J Basic Clin Pharm       Date:  2016-12

3.  Type D Personality Associated With Increased Risk for Mortality in Adults With Congenital Heart Disease.

Authors:  Dirkjan Kauw; Dounya Schoormans; Gertjan Tj Sieswerda; Joost P Van Melle; Hubert W Vliegen; Arie P J Van Dijk; Mariët S Hulsbergen-Zwarts; Marco C Post; Tieneke J Ansink; Barbara J M Mulder; Berto J Bouma; Mark J Schuuring
Journal:  J Cardiovasc Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.083

4.  Factors Influencing Physical Activity in Adolescents with Complex Congenital Heart Disease.

Authors:  Su Jin Kwon; Eun Kyoung Choi; Kyung Hee Lee; Yu-Mi Im
Journal:  Child Health Nurs Res       Date:  2019-07-31

5.  Patient-Reported Outcomes in a Multidisciplinary Electrophysiology-Psychology Ventricular Arrhythmia Clinic.

Authors:  Uday Sandhu; Andrew T Nguyen; John Dornblaser; Andrew Gray; Karen Paladino; Charles A Henrikson; Adrienne H Kovacs; Babak Nazer
Journal:  J Am Heart Assoc       Date:  2022-07-29       Impact factor: 6.106

6.  Response shift after coronary revascularization.

Authors:  Tom H Oreel; Pythia T Nieuwkerk; Iris D Hartog; Justine E Netjes; Alexander B A Vonk; Jorrit Lemkes; Hanneke W M van Laarhoven; Michael Scherer-Rath; José P S Henriques; Frans J Oort; Mirjam A G Sprangers; Mathilde G E Verdam
Journal:  Qual Life Res       Date:  2021-06-22       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.